|
LIFE SCIENCES INDUSTRY NEWSCENTER |
COMPETITIVE INTELLIGENCE PERIODICAL REPORTS |
LIFE SCIENCES INDUSTRY
MUSICAL CHAIRS: THE BLOG |
| PREVIEW |
Free Trial |
Sample Publications |
Visit |
|
Subscribe |
Subscribe |
|
| |
|
|
|
| |
|
|
|
| HOMEPAGE |
INTRODUCTION |
|
www.biotech-intelligence.net |
| ABOUT
US |
|
| LINKS |
In 2003,
we developed our life sciences industry web-based primary information
platform. Constantly, life sciences industry
announcements are collected worldwide, saved in a unique database, and
made available to subscribers through the historically named www.biotech-intelligence.net website - also accessible at
www.biotech-intelligence.com. |
| MEDIA |
| |
| DEMOS |
COVERED INDUSTRIES |
|
|
| LEGAL
INFO |
|
| CONTACT
US |
Despite its
somehow misleading domain name, www.biotech-intelligence.net covers much more
than the biotech segments (red, white and green biotech). We also collect primary
information from the pharma,
biopharma, vaccine and diagnostics industries as well as from the API, labtech, medtech and nutraceuticals industries. These announcements
come to us from established, public corporations as well as from
privately-owned early-stage ventures. Additionnally, venture capital
funds, bioincubators and
university-related or independant technology transfer firms are also included in our sources list. |
|
| 7-DAY FREE TRIAL |
| SUBSCRIPTION |
|
|
|
FIGURES |
|
|
|
|
|
|
We collected 100.000 announcements from an
ever-increasing number of industry and academy sources within a three years
time period. As of July 2006, more than 12.000 sources were on our radar. From January 1st, 2006 to June
30, 2006, we added 16.408 announcements to the database. |
|
|
|
APPLICATIONS |
|
|
|
|
|
|
This competitive intelligence website is available to subscribers who have access to the
three basic applications of www.biotech-intelligence.net, ie: 1. scan the
whole announcements archive with a world-class embedded text-mining software allowing users to simply make basic or really sophisticated
queries; 2. customize as many e-mail alerts as wished, therefore allowing
"passive intelligence"; and 3. save the work done with a dynamic
(updated) queries and related-results storage
system. |
|
|
|
|
|
COST-EFFECTIVENESS |
|
|
|
|
|
It is a
widespread opinion to consider that an effective and powerful competitive
intelligence system is expensive. Software and hardware acquisition,
training, payroll and related costs can amount to thousands of dollars. CFOs
and valuable investors appreciate our solution which starts at US$ 990 yearly
for a single
authorized user, while
- in large corporations -, a 50 authorized users yearly license
fee amounts to US$ 19.000. |
|
|
|
|
USERS |
|
|
|
|
|
Early
adopters of www.biotech-intelligence.net were European biotech
industry decision-makers at the start of our venture. Since, global middle-sized and large pharma and medtech companies executives have joined
our first customers. We have now customers in Europe, America and
Australasia. Business
Intelligence teams, Business Development & Licensing executives, Clinical Development executives as
well as early-stage firms' CEOs are the core users of our systems. |
|
|
|
|
7-DAY FREE
TRIAL OFFER |
|
|
|
|
|
To benefit from this non-binding offer, click on
the following link and fill the required fields: |
|
www.biotech-intelligence.net/register.php |
|
|
|
|
Once
registered, you will be sent a login and a password allowing full access to
license-included features. Before using the site, we suggest you view an
online demo which can be downloaded by clicking on the following link: |
|
|
Biotech-Intelligence Demo |
|
|
|
|
SUBSCRIBE
TO www.biotech-intelligence.net |
|
|
|
|
Yearly rates can be downloaded here: |
Biotech-Intelligence Subscription Rates |
|
|
|
|
|
|
Get a subscription license? Contact us: |
christian.girard@biotech-intelligence.net |
|
|
|
|
|
|
|
|
|
|
|
| Filing |
Co-Marketing |
Drug Pipeline |
Product Withdrawal |
| Clinical Trials |
NDA |
Class Action |
Marketing Authorization |
| Bioterrorism |
Regulatory |
Development Discontinuation |
Pivotal Trial |
| FDA |
Compassionate Use |
Orphan Drug Status |
Scientific Advisory Board |
| Science |
Financing Round |
London Stock Exchange |
EMEA |
| Investigators |
Unmet Medical Need |
Licensing Agreement |
USPTO |
| |
|
|
|
|
CopyrightŠ 2006-2007 HiTIS sarl |
All Rights Reserved |
Privacy Policy |
|
|
|
|